Volition issues business review 2023

Henderson, nev. , jan. 4, 2024 /prnewswire/ -- volitionrx limited (nyse american: vnrx) ("volition"), a multi-national epigenetics company, has issued a business review of 2023, outlining its key highlights from the past year.

VNRX Ratings Summary

VNRX Quant Ranking